Fundraising Fox
/Companies
Sign in

ApoGlyx

Aarhus, DK · Founded 2015 · 4 employees on LinkedIn · 2 known investors

Find your way into ApoGlyx

Sign up to see every warm intro you have to ApoGlyx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ApoGlyx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

ApoGlyx develops small-molecule aquaporin-9 inhibitors to treat severe inflammatory and metabolic diseases, including acute pancreatitis and diabetes. The company progresses its lead candidate RG210179 through clinical development and collaborates with academic institutions on drug discovery and validation.

BiotechHealthtechMedical Devices

Founders & leadership

ApoGlyx was founded in 2015 by Michael Rützler and Søren Nielsen.

MRMichael Rützler
Michael RützlerChief Executive Officer & Co-founderMichael Rützler is CEO and co-founder of ApoGlyx AB, a Lund-based company developing aquaporin inhibitors for metabolic and inflammatory diseases. He founded the company based on his academic research on aquaporin channel function and the discovery of aquaporin inhibitors.
SN
Søren NielsenCo-founder

Investors · 2

Almi InvestreportedGothenburg · $100K – $1M

How we know: funding news · nordiclifescience.org · the VCSheet dataset · Not right? Tell us

Frequently asked questions

What does ApoGlyx do?
ApoGlyx develops small-molecule aquaporin-9 inhibitors to treat severe inflammatory and metabolic diseases, including acute pancreatitis and diabetes. The company progresses its lead candidate RG210179 through clinical development and collaborates with academic institutions on drug discovery and validation.
Who founded ApoGlyx?
ApoGlyx was founded by Michael Rützler, Søren Nielsen in 2015.
Who are ApoGlyx's investors?
ApoGlyx's investors include LU Innovation, Almi Invest.
Where is ApoGlyx headquartered?
ApoGlyx is headquartered in Aarhus, DK.